Skip to main content Skip to main navigation menu Skip to site footer

Profile of ameloblastoma patients at Dr. Soetomo general hospital, Surabaya: A descriptive study

  • Muhammad Furqan Hidayat ,
  • Marjono Dwi Wibowo ,

Abstract

Link of Video Abstract: https://youtu.be/_nqEUazGnE0

 

Background: Ameloblastoma is a rare odontogenic epithelial tumor affecting the jawbone (maxilla or mandible). According to the WHO in 2005, there are four different classifications of ameloblastoma: solid or multicystic, unicystic, peripheral, and desmoplastic. Despite being benign, ameloblastoma can seriously damage bones, resulting in deformity and even death. This research aims to know the profile of ameloblastoma due to limited data in Indonesia.

Methods: This study is an observational descriptive study. Cross-sectional data collection was used. Information was gathered from the medical records of patients with ameloblastoma treated at Dr. Soetomo general hospital, Surabaya between January 2018 and December 2022. A descriptive analysis was conducted to determine the frequency and proportion of each research variable.

Results: Forty-two ameloblastoma patients participated in the study. Patients with ameloblastoma ranged in age from 14 to 75, with a mean age of 39.6 (15.7) years. The majority of patients (57.1%) were female. The majority of the cases were mandibular ameloblastoma. Only 4.8% of ameloblastoma cases occurred in the maxilla, while 76.2% of ameloblastoma locations were found in the left mandible. Up to 97.61% of the surgeries conducted include extensive resection. Most patients (95.2%) with ameloblastoma had successful outcomes.

Conclusion: Although rare, the profile of ameloblastoma patients reveals that there are still incidences of fatality, necessitating further discussion of patient mortality risk factors.

References

  1. Hendra FN, Natsir Kalla DS, Van Cann EM, de Vet HCW, Helder MN, Forouzanfar T. Radical vs conservative treatment of intraosseous ameloblastoma: Systematic review and meta-analysis. Vol. 25, Oral Diseases. 2019. doi: 10.1111/odi.13014
  2. Kelppe J, Hagström J, Sorsa T, Suominen AL, Apajalahti S, Haglund C, et al. Ameloblastoma: a retrospective single institute study of 34 subjects. Acta Odontol Scand. 2019;77(1). doi: 10.1080/00016357.2018.1532530
  3. Gurram P, Narayanan P, Chandran S, Rathan AC L. Role of Conservative Management in Treating Ameloblastoma of Jaw Bones: A Review of Literature. J Dent Heal Oral Res. 2022;03(01). doi: 10.46889/jdhor.2022.3101
  4. Giraddi GB, Arora K, Saifi AM. Ameloblastoma: A retrospective analysis of 31 cases. Vol. 7, Journal of Oral Biology and Craniofacial Research. 2017. doi: 10.1016/j.jobcr.2017.08.007
  5. Anpalagan A, Tzortzis A, Twigg J, Wotherspoon R, Chengot P, Kanatas A. Current practice in the management of peripheral ameloblastoma: a structured review. Vol. 59, British Journal of Oral and Maxillofacial Surgery. 2021. doi: 10.1016/j.bjoms.2020.08.084
  6. Chae MP, Smoll NR, Hunter-Smith DJ, Rozen WM. Establishing the natural history and growth rate of ameloblastoma with implications for management: Systematic review and meta-analysis. Vol. 10, PLoS ONE. 2015. doi: 10.1371/journal.pone.0117241
  7. Wibowo MD, Fathurochman AF. Aggressiveness tumor: A case report of recurrent ameloblastoma in the mandible. Bali Med J. 2021;10(1). doi: 10.15562/bmj.v10i1.2114

How to Cite

Hidayat, M. F., & Marjono Dwi Wibowo. (2023). Profile of ameloblastoma patients at Dr. Soetomo general hospital, Surabaya: A descriptive study. Bali Medical Journal, 12(3), 3098–3100. https://doi.org/10.15562/bmj.v12i3.4829

HTML
5

Total
4

Share

Search Panel

Muhammad Furqan Hidayat
Google Scholar
Pubmed
BMJ Journal


Marjono Dwi Wibowo
Google Scholar
Pubmed
BMJ Journal